Brief: Dermapharm Holding Confirms FY Outlook

Dermapharm Holding SE

14/11/2024 06:47

Nov 14 (Reuters) - Dermapharm Holding SE  DMPG.DE :
    * DERMAPHARM HOLDING SE - 9M ADJUSTED EBITDA MARGIN 27% 
    * DERMAPHARM HOLDING SE - 9M REVENUE 890.1 EUR MILLION
    * DERMAPHARM HOLDING SE  - 9M EBT AT EUR 137.5 MILLION
    * DERMAPHARM HOLDING SE - 9M UNADJ EBITDA MARGIN 26.3%
    * DERMAPHARM HOLDING SE - 9M EPS AT EUR 1.73
    * DERMAPHARM HOLDING SE - 9M OP RESULT EUR 169.1 MILLION
    * DERMAPHARM HOLDING SE  - 9M PROFIT FOR THE PERIOD OF 92.7
MILLION EUR
    * DERMAPHARM HOLDING SE - CONFIRMS OUTLOOK

Source text:  ID:nEQ1lHSJma 
Further company coverage:  DMPG.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))